Wium-Andersen IK, Wium-Andersen MK, Fink-Jensen A, et al
Morling said his team was trying to tackle the problem "at its root", acknowledging "there's an organised crime group behind most of these [websites]" and the unit is "working proactively to take out the criminals themselves"
The coaching access is a plus, and the variety of dosage forms gives patients options
Cost and coverage have shifted meaningfully, and some older guidance is now wrong
Retatrutide targets more hormone pathways than nearly any approved weight loss medications
Phase 2 (2022-2023) Phase 2 trial results generated significant attention in the medical community: Obesity trial results were published in the New England Journal of Medicine in 2023, showing weight loss of up to 24.2% at the highest dose over 48 weeks